BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20696896)

  • 1. Tracing the protectors path from the germ line to the genome.
    Coutandin D; Ou HD; Löhr F; Dötsch V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15318-25. PubMed ID: 20696896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
    Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
    Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
    Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One billion years of p53/p63/p73 evolution.
    Belyi VA; Levine AJ
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17609-10. PubMed ID: 19826090
    [No Abstract]   [Full Text] [Related]  

  • 5. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
    Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
    Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
    Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
    Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional domains in p53 family proteins exhibit both common and distinct properties.
    Harms KL; Chen X
    Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
    [No Abstract]   [Full Text] [Related]  

  • 9. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.
    Brandt T; Petrovich M; Joerger AC; Veprintsev DB
    BMC Genomics; 2009 Dec; 10():628. PubMed ID: 20030809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 and p63: why do we still need them?
    Blandino G; Dobbelstein M
    Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63: the phantom of the tumor suppressor.
    Finlan LE; Hupp TR
    Cell Cycle; 2007 May; 6(9):1062-71. PubMed ID: 17426453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 family members: similar biochemistry, different biology.
    Barbieri CE; Pietenpol JA
    Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
    van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
    Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.
    Glazko GV; Koonin EV; Rogozin IB
    Biochim Biophys Acta; 2004 Aug; 1679(2):95-106. PubMed ID: 15297143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 and p73, the ancestors of p53.
    Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.